Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.

Loading...
Thumbnail Image

Embargo End Date

Authors

Vijayakrishnan, J
Qian, M
Studd, JB
Yang, W
Kinnersley, B
Law, PJ
Broderick, P
Raetz, EA
Allan, J
Pui, C-H
Vora, A
Evans, WE
Moorman, A
Yeoh, A
Yang, W
Li, C
Bartram, CR
Mullighan, CG
Zimmerman, M
Hunger, SP
Schrappe, M
Relling, MV
Stanulla, M
Loh, ML
Houlston, RS
Yang, JJ

Document Type

Journal Article

Date

2019-11-25

Date Accepted

2019-10-17

Abstract

There is increasing evidence for a strong inherited genetic basis of susceptibility to acute lymphoblastic leukaemia (ALL) in children. To identify new risk variants for B-cell ALL (B-ALL) we conducted a meta-analysis with four GWAS (genome-wide association studies), totalling 5321 cases and 16,666 controls of European descent. We herein describe novel risk loci for B-ALL at 9q21.31 (rs76925697, P = 2.11 × 10-8), for high-hyperdiploid ALL at 5q31.1 (rs886285, P = 1.56 × 10-8) and 6p21.31 (rs210143 in BAK1, P = 2.21 × 10-8), and ETV6-RUNX1 ALL at 17q21.32 (rs10853104 in IGF2BP1, P = 1.82 × 10-8). Particularly notable are the pleiotropic effects of the BAK1 variant on multiple haematological malignancies and specific effects of IGF2BP1 on ETV6-RUNX1 ALL evidenced by both germline and somatic genomic analyses. Integration of GWAS signals with transcriptomic/epigenomic profiling and 3D chromatin interaction data for these leukaemia risk loci suggests deregulation of B-cell development and the cell cycle as central mechanisms governing genetic susceptibility to ALL.

Citation

Nature communications, 2019, 10 (1), pp. 5348 - ?

Source Title

Publisher

NATURE PORTFOLIO

ISSN

2041-1723

eISSN

2041-1723

Research Team

Cancer Genomics

Notes